Anal Squamous Cell Carcinoma in the HIV-Positive Patient

 

 Buy Article Permissions and Reprints

ABSTRACT

Epidermoid carcinoma of the anal canal is uncommon. The incidence of this disease has increased in HIV-positive men who have sex with men and the disease process is different from in HIV-negative patients. Modern therapy of HIV with highly active antiretroviral therapy (HAART) has improved the overall survival of HIV patients and allowed effective therapy for those who develop epidermoid carcinoma of the anal canal. This article describes the disease process and current treatment options.

REFERENCES

• 1 National Cancer Institute . Surveillance, Epidemiology, and End Results (SEER) Program.  Available at: http://seer.cancer.gov/csr/1975_2005/results_merged/sect_01_overview.pdf Accessed February 28, 2009; 
  PubMedGoogle Scholar
• 2 Diamond C, Taylor T H, Aboumrad T, Bringman D, Anton-Culver H. Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy.  Sex Transm Dis. 2005;  32(5) 314-320
  PubMedGoogle Scholar
• 3 Piketty C, Selinger-Leneman H, Grabar S FHDH-ANRS CO 4 et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy.  AIDS. 2008;  22(10) 1203-1211
  CrossrefPubMedGoogle Scholar
• 4 Ryan D P, Compton C C, Mayer R J. Carcinoma of the anal canal.  N Engl J Med. 2000;  342(11) 792-800
  CrossrefPubMedGoogle Scholar
• 5 Palefsky J M. Human papillomavirus-related tumors.  AIDS. 2000;  14(Suppl 3) S189-S195
  CrossrefPubMedGoogle Scholar
• 6 Cooper K, McGee J O. Human papillomavirus, integration and cervical carcinogenesis: a clinicopathological perspective.  Mol Pathol. 1997;  50(1) 1-3
  PubMedGoogle Scholar
• 7 Gervaz P, Hahnloser D, Wolff B G et al.. Molecular biology of squamous cell carcinoma of the anus: a comparison of HIV-positive and HIV-negative patients.  J Gastrointest Surg. 2004;  8(8) 1024-1030, discussion 1031
  CrossrefPubMedGoogle Scholar
• 8 Kreuter A, Brockmeyer N H, Altmeyer P, Wieland U. German Competence Network HIV/AIDS . Anal intraepithelial neoplasia in HIV infection.  J Dtsch Dermatol Ges. 2008;  6(11) 925-934
  PubMedGoogle Scholar
• 9 Gervaz P, Hirschel B, Morel P. Molecular biology of squamous cell carcinoma of the anus.  Br J Surg. 2006;  93(5) 531-538
  CrossrefPubMedGoogle Scholar
• 10 Goldstone S. Anal dysplasia in men who have sex with men.  AIDS Read. 1999;  9(3) 204-208, 220
  PubMedGoogle Scholar
• 11 Patel H S, Silver A R, Northover J M. Anal cancer in renal transplant patients.  Int J Colorectal Dis. 2007;  22(1) 1-5
  PubMedGoogle Scholar
• 12 Mathews W C, Sitapati A, Caperna J C, Barber R E, Tugend A, Go U. Measurement characteristics of anal cytology, histopathology, and high-resolution anoscopic visual impression in an anal dysplasia screening program.  J Acquir Immune Defic Syndr. 2004;  37(5) 1610-1615
  CrossrefPubMedGoogle Scholar
• 13 Arain S, Walts A E, Thomas P, Bose S. The anal Pap smear: cytomorphology of squamous intraepithelial lesions.  Cytojournal. 2005;  2(1) 4
  CrossrefPubMedGoogle Scholar
• 14 Chiao E Y, Giordano T P, Palefsky J M, Tyring S, El Serag H. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review.  Clin Infect Dis. 2006;  43(2) 223-233
  CrossrefPubMedGoogle Scholar
• 15 Ferraris A, Narasimhan K, Rahman I, Jorge I. Anal Pap smear in high-risk patients: a poor screening tool.  South Med J. 2008;  101(11) 1185-1186
  PubMedGoogle Scholar
• 16 Cantor S B, Atkinson E N, Cardenas-Turanzas M, Benedet J L, Follen M, MacAulay C. Natural history of cervical intraepithelial neoplasia: a meta-analysis.  Acta Cytol. 2005;  49(4) 405-415
  PubMedGoogle Scholar
• 17 Ostör A G. Natural history of cervical intraepithelial neoplasia: a critical review.  Int J Gynecol Pathol. 1993;  12(2) 186-192
  PubMedGoogle Scholar
• 18 Mathews C, Caperna J, Cachay E R, Cosman B. Early impact and performance characteristics of an established anal dysplasia screening program: program evaluation considerations.  Open AIDS J. 2007;  1 11-20
  PubMedGoogle Scholar
• 19 Goldstone S E, Hundert J S, Huyett J W. Infrared coagulator ablation of high-grade anal squamous intraepithelial lesions in HIV-negative males who have sex with males.  Dis Colon Rectum. 2007;  50(5) 565-575
  CrossrefPubMedGoogle Scholar
• 20 Nathan M, Hickey N, Mayuranathan L, Vowler S L, Singh N. Treatment of anal human papillomavirus-associated disease: a long term outcome study.  Int J STD AIDS. 2008;  19(7) 445-449
  CrossrefPubMedGoogle Scholar
• 21 Kreuter A, Potthoff A, Brockmeyer N H German Competence Network HIV/AIDS et al. Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men.  J Invest Dermatol. 2008;  128(8) 2078-2083
  CrossrefPubMedGoogle Scholar
• 22 Chiao E Y, Krown S E, Stier E A, Schrag D. A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic.  J Acquir Immune Defic Syndr. 2005;  40(4) 451-455
  CrossrefPubMedGoogle Scholar
• 23 Romassi M, Nagle D. Images in HIV/AIDS. The changing face of anal cancer.  AIDS Read. 2008;  18(4) 185-187
  PubMedGoogle Scholar
• 24 Nigro N D, Vaitkevicius V K, Considine Jr B. Combined therapy for cancer of the anal canal: a preliminary report.  Dis Colon Rectum. 1974;  17(3) 354-356
  CrossrefPubMedGoogle Scholar
• 25 Stadler R F, Gregorcyk S G, Euhus D M, Place R J, Huber P J, Simmang C L. Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy.  Dis Colon Rectum. 2004;  47(8) 1305-1309
  CrossrefPubMedGoogle Scholar
• 26 Kim J H, Sarani B, Orkin B A et al.. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients.  Dis Colon Rectum. 2001;  44(10) 1496-1502
  CrossrefPubMedGoogle Scholar
• 27 Edelman S, Johnstone P A. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.  Int J Radiat Oncol Biol Phys. 2006;  66(1) 206-211
  CrossrefPubMedGoogle Scholar
• 28 Oehler-Jänne C, Huguet F, Provencher S et al.. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy.  J Clin Oncol. 2008;  26(15) 2550-2557
  CrossrefPubMedGoogle Scholar
• 29 Wexler A, Berson A M, Goldstone S E et al.. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.  Dis Colon Rectum. 2008;  51(1) 73-81
  CrossrefPubMedGoogle Scholar
• 30 Seo Y, Kinsella M T, Reynolds H L, Chipman G, Remick S C, Kinsella T J. Outcomes of chemoradiotherapy with 5-fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.  Int J Radiat Oncol Biol Phys. 2009;  , Epub ahead of print
  PubMedGoogle Scholar
• 31 Chiao E Y, Giordano T P, Richardson P, El-Serag H B. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era.  J Clin Oncol. 2008;  26(3) 474-479
  CrossrefPubMedGoogle Scholar
• 32 Schiller D E, Cummings B J, Rai S et al.. Outcomes of salvage surgery for squamous cell carcinoma of the anal canal.  Ann Surg Oncol. 2007;  14(10) 2780-2789
  CrossrefPubMedGoogle Scholar

Deborah NagleM.D. 

Beth Israel Deaconess Medical Center

330 Brookline Ave., Stoneman 9, Boston, MA 02215

Email: dnagle@bidmc.harvard.edu